UNP
49
4
CB
60
3
HPE
52
-2
ESS
31
3
PNW
66
7
AMGN
47
-2
RHI
42
2
TSN
50
2
MCHP
72
-3
CVX
40
5
OI
58
2
AVY
53
7
THC
59
3
UNH
40
3
CVS
52
3
SJM
28
7
NVDA
52
-5
FOXA
64
2
KSS
67
4
SE
61
-7
UNP
49
4
CB
60
3
HPE
52
-2
ESS
31
3
PNW
66
7
AMGN
47
-2
RHI
42
2
TSN
50
2
MCHP
72
-3
CVX
40
5
OI
58
2
AVY
53
7
THC
59
3
UNH
40
3
CVS
52
3
SJM
28
7
NVDA
52
-5
FOXA
64
2
KSS
67
4
SE
61
-7
Financhill
Back

iShares Morningstar Mid-Cap Growth ETF Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Buy
53

IMCG
iShares Morningstar Mid-Cap Growth ETF

Last Price:
$82.53
Seasonality Move:
3.1%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$55.06
Seasonality Move:
-11.9%
Buy
53
iShares Morningstar Mid-Cap Growth ETF (IMCG) is a Buy

Is iShares Morningstar Mid-Cap Growth ETF a Buy, Sell or Hold?

  • The current iShares Morningstar Mid-Cap Growth ETF [IMCG] share price is $81.73. The Score for IMCG is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
  • IMCG is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IMCG Stock Price Chart

What is iShares Morningstar Mid-Cap Growth ETF's stock price today?

  • The iShares Morningstar Mid-Cap Growth ETF share price today is $81.73
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IMCG is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

IMCG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.3 Buy
Relative Strength Index (14 RSI): 53.97 Buy
Chaikin Money Flow: -67518 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (80.28 - 81.8) Buy
Bollinger Bands (100): (80.31 - 82.71) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

IMCG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 81.44 Buy
20-day SMA: 81.04 Buy
50-day SMA: 80.93 Buy
200-day SMA: 78.88 Buy
8-day EMA: 81.57 Buy
20-day EMA: 81.17 Buy
50-day EMA: 80.14 Buy
200-day EMA: 54.55 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

iShares Morningstar Mid-Cap Growth ETF Earnings Growth & IMCG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

iShares Morningstar Mid-Cap Growth ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):